Showing results (831-840 of 31,429) with videos related to

Sort By:
Pageof 3,143
Antimicrobial Agents and Chemotherapy|July 30, 2008
Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapyGraeme N Forrest, Mary-Claire Roghmann, Latoya S Toombs, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2008
WITHDRAWN: Very strong synergy between modified RANTES and gp41 binding peptides leads to potent anti-HIV-1 activityHongjun Jin, Edward B Siwak, Roger Smith, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2008
Microbial growth inhibition by alternating electric fieldsMoshe Giladi, Yaara Porat, Alexandra Blatt, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2008
Evolution of the ISCR3 group of ISCR elementsMark A Toleman, Timothy R Walsh
Antimicrobial Agents and Chemotherapy|July 30, 2008
Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. communityNancy D Hanson, Ellen Smith Moland, S G Hong, et al.
Antimicrobial Agents and Chemotherapy|September 27, 2021
Monoclonal Antibodies against Cell Wall Chitooligomers as Accessory Tools for the Control of CryptococcosisAlexandre Bezerra Conde Figueiredo, Fernanda L Fonseca, Diogo Kuczera, et al.
Antimicrobial Agents and Chemotherapy|September 27, 2021
Impact of HIV-1 Resistance-Associated Mutations on Susceptibility to Doravirine: Analysis of Real-World Clinical IsolatesErnest Asante-Appiah, Johnny Lai, Hong Wan, et al.
Antimicrobial Agents and Chemotherapy|February 7, 2022
Safety, Tolerability, Pharmacokinetics, and Acceptability of Oral and Long-Acting Cabotegravir in HIV-Negative Chinese MenKelong Han, Paul Wannamaker, Hongzhou Lu, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2021
Synergy Mechanisms of Daptomycin-Fosfomycin Combinations in Daptomycin-Susceptible and -Resistant Methicillin-Resistant Staphylococcus aureus: In Vitro, Ex Vivo, and In Vivo MetricsNagendra N Mishra, Cassandra Lew, Wessam Abdelhady, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2021
Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological StudyOguz Kagan Bakkaloglu, Ozgen Yildirim, Bilger Cavus, et al.
Pageof 3,143